Structure
Pioglitazone is a TZD with a thiazolidinedione ring substituted with a pyridine moiety, enhancing its binding affinity to PPAR-γ.
Chemical Formula: C₁₄H₁₈N₂O₂S
Mode of Action
PPAR-γ Agonism: Enhances insulin sensitivity by modulating gene expression related to glucose and lipid metabolism.
Adipocyte Differentiation: Promotes the formation of insulin-sensitive adipocytes.
Uses
Type 2 Diabetes Mellitus: Improves glycemic control by increasing insulin sensitivity.
Dyslipidemia: Reduces triglycerides and increases HDL cholesterol levels.
Non-Alcoholic Steatohepatitis (NASH): Investigated for its role in reducing liver fat and inflammation.